Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 10Breast Diseases 2Sexuality 1Polycystic Ovary Syndrome 1Neoplasms, Hormone-Dependent 1Luminal B/HER2-negative Breast Cancer 1Infertility 1Hormone-receptor-positive Breast Cancer 1Hormone Receptor Positive Advanced Breast Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Advanced Breast Cancer 1

Interventions

Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Luminal B/HER2-negative Breast Cancer × Aromatase Inhibitors × Clear all
NCT05640778 2024-01-31

Neoadjuvant Dalpiciclib Plus Aromatase Inhibitors in Luminal B/HER2-negative Breast Cancer (DANCER)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 2 Unknown
30 enrolled
Breast

Luminal B/HER2-negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡